Ever optimistic! Not sure of what this may or may not imply?!
This is an extract from a proposed NICE appraisal.
Suggested remit:
To appraise the clinical and cost effectiveness of dasatinib within its licensed indication for the first line treatment of chronic myeloid leukaemia.
http://www.nice.org.uk/ourguidance/niceguidancebytype/technologyappraisa...